Aligos Therapeutics, Inc. (ALGS)

NASDAQ: ALGS · IEX Real-Time Price · USD

0.400

+0.031 (8.40%)

At close: Jul 2, 2024, 4:00 PM

0.387

-0.013 (-3.25%)

After-hours: Jul 2, 2024, 7:45 PM EDT

Aligos Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-87.68	-96.05	-128.33	-108.54	-52.26	Upgrade
Depreciation & Amortization	3.07	3.68	3.78	3.33	2.3	Upgrade
Share-Based Compensation	12.65	14.69	13.46	2.98	0.75	Upgrade
Other Operating Activities	-7.04	-1.71	-4.57	27.98	2.45	Upgrade
Operating Cash Flow	-79	-79.39	-115.66	-74.26	-46.77	Upgrade
Capital Expenditures	-0.02	-0.94	-0.89	-2.06	-2.79	Upgrade
Change in Investments	45	-25.35	3.91	34.82	9.58	Upgrade
Investing Cash Flow	44.98	-26.29	3.02	32.76	6.79	Upgrade
Share Issuance / Repurchase	43.44	0.23	79.63	155.8	0.49	Upgrade
Debt Issued / Paid	-0.1	-0.06	-0.08	-0.06	-0.04	Upgrade
Other Financing Activities	44.98	-	-0.88	36.6	85.09	Upgrade
Financing Cash Flow	88.33	0.16	78.68	192.35	85.53	Upgrade
Net Cash Flow	54.31	-105.52	-33.96	150.84	45.56	Upgrade
Free Cash Flow	-79.02	-80.33	-116.55	-76.33	-49.55	Upgrade
Free Cash Flow Margin	-508.83%	-577.64%	-2673.87%	-	-	Upgrade
Free Cash Flow Per Share	-1.23	-1.88	-2.92	-7.64	-24.69	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).